At GERNA Biotech, we are pioneering Cas-free gene editing technologies that eliminate the need for Cas proteins, offering safer and more efficient solutions to genetic disorders, and opening new possibilities in genetic therapy.
Our Cas-free technology eliminates the risk of double-strand breaks, ensuring safer gene editing.
Using over 30 bp guide-RNA, minimizes off-target effects, enhancing precision.
Without PAM constraints, our design allows for broader and more versatile gene editing applications.
If you have any questions or need more information about GERNA Biotech, please feel free to reach out to us.
913, 456-DongDaeGu-Ro, Dong-gu, Daegu, South-Korea